[Federal Register Volume 81, Number 181 (Monday, September 19, 2016)]
[Notices]
[Page 64131]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-22480]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-60-2016]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification 
of Proposed Production Activity; MSD International GMBH (Puerto Rico 
Branch) LLC; Subzone 7G (Pharmaceuticals) Las Piedras, Puerto Rico

    MSD International GMBH (Puerto Rico Branch) LLC (MSD), operator of 
Subzone 7G, submitted a notification of proposed production activity to 
the FTZ Board for its facility within Subzone 7G, in Las Piedras, 
Puerto Rico. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on August 29, 
2016.
    MSD currently has authority to produce certain pharmaceutical 
products and their intermediates within Subzone 7G. The current request 
would add a finished pharmaceutical product and foreign status 
materials/components to the scope of authority. Pursuant to 15 CFR 
400.14(b), additional FTZ authority would be limited to the specific 
foreign-status materials/components and specific finished product 
described in the submitted notification (as described below) and 
subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt MSD from customs duty 
payments on the foreign-status materials/components used in export 
production. On its domestic sales, MSD would be able to choose the duty 
rate during customs entry procedures that applies to finished 
ertugliflozin/metformin pharmaceutical tablets for the treatment of 
type-2 diabetes (duty free) for the foreign-status materials/components 
noted below and in the existing scope of authority. Customs duties also 
could possibly be deferred or reduced on foreign-status production 
equipment.
    The materials/components sourced from abroad include: Metformin 
hydrochloride and jet-milled ertugliflozin active ingredients (duty 
rates 3.7% and 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the FTZ Board's Executive Secretary at the 
address below. The closing period for their receipt is October 31, 
2016.
    A copy of the notification will be available for public inspection 
at the Office of the Executive Secretary, Foreign-Trade Zones Board, 
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW., 
Washington, DC 20230-0002, and in the ``Reading Room'' section of the 
FTZ Board's Web site, which is accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
[email protected] or (202) 482-1367.

    Dated: September 13, 2016.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2016-22480 Filed 9-16-16; 8:45 am]
 BILLING CODE 3510-DS-P